Elon Musk's Tesla Suffered Its Worst Week Since 2022, Wiping Out $130 Billion of His Fortune. Is the Stock Still a Buy?

Tesla shares fell 18% after Q2 results despite revenue rising 26% to $28.23B and deliveries up 25% to 480,126. The disappointment was a sharp profit hit: operating expenses surged 47% to $4.35B, EPS was $0.33 vs $0.54 consensus, and free cash flow turned negative at -$1.1B (cash & investments down $1.2B). Capex more than doubled sequentially, with plans to spend over $25B in the second half and borrow up to $30B for capex, which supports a multi-year buildout but keeps near-term profitability risk elevated.

Analysis

TSLA’s problem is not demand; it is capital allocation. When growth is being funded by a step-up in capex while operating leverage is disappearing, the market stops valuing the business like a scale platform and starts valuing it like a long-duration project finance story, which compresses multiple and raises the bar for execution. That matters for credit too: incremental debt capacity helps bridge the gap, but it also increases the probability that equity bears the burden if near-term cash conversion does not improve.

The second-order winner is AMZN, not because it is cheaper, but because the market is clearly rewarding visible monetization of investment. Capital spending with measurable payback supports a premium multiple; capital spending with aspirational end-markets does the opposite. NVDA also benefits indirectly if the market continues to favor AI infrastructure exposure over consumer-robotics optionality, but TSLA’s push into autonomy/Optimus is too far from commercial proof to compete for “AI capex” status in the near term.

Over the next 1-3 months, the stock is vulnerable to any sign that margins cannot stabilize before capex ramps again, especially if free cash flow remains negative into the next print. Over 6-18 months, the key reversal would be evidence that autonomy monetization is moving from demo to recurring revenue; absent that, the equity risks becoming hostage to funding costs and sentiment cycles. The contrarian miss is that the recent bounce may be read as a durable bottom when it is more likely a reflexive dip-buying reaction in a still-deteriorating fundamentals regime.

Key Decisions for Investors

• Short TSLA on rallies over the next 2-4 weeks; thesis is that the market will continue to de-rate a company funding multi-year capex with weak FCF and no near-term margin repair. Cover if management shows two consecutive quarters of gross margin and FCF inflection.
• Pair long AMZN / short TSLA for a 1-3 month relative-value trade: both are capex-heavy, but AMZN has visible payoff in core economics while TSLA is still pre-commercial on its highest-IRR narratives. This should work if the market keeps paying up for proven AI returns and penalizing speculative optionality.
• Use TSLA as a watch item for credit stress rather than an outright equity-only story: if debt issuance widens spreads or the company leans harder on leverage to fund capex, that is a signal to add to the short. Falsifier is successful financing at tight spreads without equity pressure.
• Avoid chasing NVDA as a direct hedge to TSLA weakness; the better expression is to own infrastructure beneficiaries with measurable demand and avoid the consumer-robotics narrative until monetization is demonstrated.